BioRestorative Therapies (BRTX) vs Matinas Biopharma (MTNB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Matinas Biopharma is the larger company by market cap ($2.8 million vs $2.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BRTX | MTNB |
|---|---|---|
| Share price | $1.89 | $2.83 |
| Market cap | $2.61M | $2.77M |
| 1-day change | -15.63% | +2.17% |
| EPS (TTM) | $-21.40 | $-17.93 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $34.40 | $28.95 |
| 52-week low | $1.75 | $2.27 |
| Distance from 52-week high | -94.51% | -90.22% |
| Analyst consensus | buy | — |
| Avg. price target upside | +15773.02% | — |
| Average volume | 26.05K | 408.10K |
| Shares outstanding | 1.38M | 979.52K |
| Employees | 13 | 2 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About BioRestorative Therapies
BRTX stock →BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
Healthcare · Biotechnology · 13 employees
About Matinas Biopharma
MTNB stock →Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides.
Healthcare · Biotechnology · 2 employees
BRTX vs MTNB FAQ
Which is bigger, BioRestorative Therapies or Matinas Biopharma?
Matinas Biopharma (MTNB) is larger, with a market capitalization of $2.77M compared with $2.61M for BioRestorative Therapies (BRTX).
Are BioRestorative Therapies and Matinas Biopharma in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.